Related content

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

By Götze Katharina   Platzbecker Uwe   Giagounidis Aristoteles   Haase Detlef   Lübbert Michael   Aul Carlo   Ganser Arnold   Germing Ulrich   Hofmann Wolf-Karsten  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 841-850

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment

By Moon Joon   Kim Shi   Kang Byung   Chae Yee   Kim Jong   Baek Jin   Park Jae   Song Moo   Chung Joo   Won Jong   Lee Sang   Joo Young   Kim Yeo   Kim Hyeong   Jo Deog   Sohn Sang  

Annals of Hematology, Vol. 89, Iss. 7, 2010-07 ,pp. : 681-689

Springer Publishing Company

Access to resources Recommend Favorite

Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses

By Giagounidis Aristoteles   Haase Sabine   Heinsch Michael   Göhring Gudrun   Schlegelberger Brigitte   Aul Carlo  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 133-137

Springer Publishing Company

Access to resources Recommend Favorite

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients

By Wijermans P.   Lübbert M.   Verhoef G.   Klimek V.   Bosly A.  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Number of Treatment Cycles Influences Development of Cytotoxic T Cells in Metastatic Breast Cancer Patients – A Phase I/II Study

By Wright Stephen E.   Rewers-Felkins Kathleen A.   Quinlin Imelda S.   Phillips Catherine A.   Townsend Mary   Philip Ramila   Zorsky Paul   Klug Panpit   Dai Lijun   Hussain Mohammad   Thomas Aabu A.   Sundaramurthy Chithraleka  

Immunological Investigations, Vol. 39, Iss. 6, 2010-01 ,pp. : 570-586

Informa Healthcare

Access to resources Recommend Favorite